The global Neuromonitoring Device market size is expected to grow at US$ 10,850.20 million in 2027 at a compound annual growth rate (CAGR) of 7.68%.
Neuromonitoring devices are medical tools that can record information on a patient's brain's blood flow, oxygen level, and electrical impulse rate while simultaneously showing the results. In hospitals, clinics, and other settings, these gadgets are frequently used. Numerous types of neuromonitoring devices, including doppler ultrasonography, computed tomography (CT scan), and magnetic resonance imaging, are offered in the market (MRI). The rising prevalence of neurological illnesses such as epilepsy, Alzheimer's disease, Parkinson's disease, and others in the elderly population, as well as the rising rate of hospitalization, are expected to fuel the expansion of the global neuromonitoring devices market during the research period. The increasing need for non-invasive and non-destructive technology as well as the expanding use of neuromonitoring devices in clinics are further factors projected to fuel market expansion. Rising technical breakthroughs in the production of neuromonitoring devices, as well as increased R&D efforts by manufacturing organizations, are some of the factors expected to generate plentiful growth prospects for the worldwide neuromonitoring devices market by 2030. Additionally, it is predicted that major market players' corporate expansion and new product releases would present excellent chances for market growth.
October 30, 2020: Medtronic receives FDA approval for NIM Vital nerve monitoring system --
Medtronic has secured Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital nerve monitoring system, which enables doctors to identify, confirm, and monitor nerve function to help cut down the risk of nerve damage during head and neck surgery.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
The market for neuromonitoring devices in North America generated $1,996.7 million in revenue in 2021 and is anticipated to reach $3,534.9 million in sales by 2030. The increase is linked to patients' growing demand for better and more modern healthcare facilities. Adoption of cutting-edge technologies could also boost North America's market revenue. In response to the increased demand for neuromonitoring devices and the increasing incidence of neurological illnesses like epilepsy, major market participants have concentrated on releasing new products in the market. In addition, it is projected that the prevalence of neurological illnesses in the North American area will further propel the market. North America will dominate the market in 2021, accounting for around 49.30% of global sales. This dominance is mostly attributable to favourable reimbursement conditions and a surge in the incidence of neurological disorders. The National Institute of Health estimates that 795,000 Americans experience a stroke year, leading to 137,000 fatalities. The Migraine Research Foundation also predicted that by 2020, 35 million Americans would experience migraine headaches. Additionally, it is anticipated that in the nation, 18% of men and 43% of women may experience migraines. Rising rates of neurological conditions like TBI, migraines, and stroke are therefore anticipated to drive market expansion in this nation.
The Neuromonitoring Device Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Neuromonitoring Device Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 7.68% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | CAS Medical, Compumedics, Philips Healthcare, AMD Telemedicine, Johnson & Johnson, InTouch Heath, Siemens Healthcare, GE Healthcare, Nihon Kohden, Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, LLC, Specialtycare, RIMED Ltd. |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 161 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Neuromonitoring Device Market?
The Neuromonitoring Device Market is growing at a CAGR of 7.68% over the next 5 years.
Who are the key players in Neuromonitoring Device Market?
CAS Medical, Compumedics, Philips Healthcare, AMD Telemedicine, Johnson & Johnson, InTouch Heath, Siemens Healthcare, GE Healthcare, Nihon Kohden, Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, LLC, Specialtycare, RIMED Ltd.
What are the significant types of Neuromonitoring Device Market?
Non-Invasive, Invasive
What are the major end-use applications of Neuromonitoring Device Market?
Hospitals, Neurological Centers and Institutions, Clinics and Ambulatory Surgical Centers, Diagnostic Centers, Others
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.